EXoZymes Company Insiders
| EXOZ Stock | 10.90 0.23 2.07% |
EXoZymes employs about 31 people. The company is managed by 10 executives with a total tenure of roughly 73 years, averaging almost 7.0 years of service per executive, having 3.1 employees per reported executive. Break down of EXoZymes' management performance can provide insight into the company performance.
EXoZymes Management Team Effectiveness
The company has return on total asset (ROA) of (0.9979) % which means that it has lost $0.9979 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.4069) %, meaning that it created substantial loss on money invested by shareholders. EXoZymes' management efficiency ratios could be used to measure how well EXoZymes manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.42 in 2026. Return On Capital Employed is likely to drop to -0.61 in 2026. At this time, EXoZymes' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 439.3 K in 2026, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2026.Common Stock Shares Outstanding is likely to drop to about 6.5 M in 2026The market capitalization of eXoZymes is USD91.42 Million. eXoZymes shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.73 percent of eXoZymes outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in stocks such as EXoZymes in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of EXoZymes, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
EXoZymes Workforce Comparison
eXoZymes is rated # 2 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 186. EXoZymes retains roughly 31.0 in number of employees claiming about 17% of equities under Health Care industry.
EXoZymes Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXoZymes insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXoZymes' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EXoZymes insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Michael Heltzen over three months ago Acquisition by Michael Heltzen of 1040 shares of EXoZymes, at 10.22 subject to Rule 16b-3 | ||
Michael Heltzen over six months ago Acquisition by Michael Heltzen of 235817 shares of EXoZymes, at 12.4 subject to Rule 16b-3 | ||
Tyler Korman over six months ago Acquisition by Tyler Korman of 2990 shares of EXoZymes, at 12.54 subject to Rule 16b-3 | ||
Fouad Nawaz over six months ago Acquisition by Fouad Nawaz of 3489 shares of EXoZymes, at 12.54 subject to Rule 16b-3 |
EXoZymes Notable Stakeholders
An EXoZymes stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EXoZymes often face trade-offs trying to please all of them. EXoZymes' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EXoZymes' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tyler Korman | CoFounder Research | Profile | |
| Paul Opgenorth | CoFounder Development | Profile | |
| Mohammad JD | Chairman CoFounder | Profile | |
| James Bowie | Founder Director | Profile | |
| Zachary Karl | VP Development | Profile | |
| Michael Heltzen | Chief Officer | Profile | |
| Fouad Nawaz | Vice Finance | Profile | |
| Damien Perriman | Chief Officer | Profile | |
| Michael Burns | Executive Transition | Profile | |
| Lasse Gorlitz | Vice Communications | Profile |
About EXoZymes Management Performance
The success or failure of an entity such as eXoZymes often depends on how effective the management is. EXoZymes management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EXoZymes management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EXoZymes management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.58) | (0.61) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (0.51) | (0.48) |
Please note, the imprecision that can be found in EXoZymes' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of eXoZymes. Check EXoZymes' Beneish M Score to see the likelihood of EXoZymes' management manipulating its earnings.
EXoZymes Workforce Analysis
Traditionally, organizations such as EXoZymes use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EXoZymes within its industry.EXoZymes Manpower Efficiency
Return on EXoZymes Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 189.1K | |
| Net Loss Per Executive | 586.1K | |
| Working Capital Per Employee | 306K | |
| Working Capital Per Executive | 948.7K |
Additional Tools for EXoZymes Stock Analysis
When running EXoZymes' price analysis, check to measure EXoZymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXoZymes is operating at the current time. Most of EXoZymes' value examination focuses on studying past and present price action to predict the probability of EXoZymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXoZymes' price. Additionally, you may evaluate how the addition of EXoZymes to your portfolios can decrease your overall portfolio volatility.